rs575791037

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001099403.2(PRDM8):​c.1412G>A​(p.Ser471Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000437 in 1,274,036 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00042 ( 2 hom. )

Consequence

PRDM8
NM_001099403.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.300

Publications

0 publications found
Variant links:
Genes affected
PRDM8 (HGNC:13993): (PR/SET domain 8) This gene encodes a protein that belongs to a conserved family of histone methyltransferases that predominantly act as negative regulators of transcription. The encoded protein contains an N-terminal Su(var)3-9, Enhancer-of-zeste, and Trithorax (SET) domain and a double zinc-finger domain. Knockout of this gene in mouse results in mistargeting by neurons of the dorsal telencephalon, abnormal itch-like behavior, and impaired differentiation of rod bipolar cells. In humans, the protein has been shown to interact with the phosphatase laforin and the ubiquitin ligase malin, which regulate glycogen construction in the cytoplasm. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
PRDM8 Gene-Disease associations (from GenCC):
  • early-onset Lafora body disease
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003796935).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRDM8NM_001099403.2 linkc.1412G>A p.Ser471Asn missense_variant Exon 4 of 4 ENST00000415738.3 NP_001092873.1 Q9NQV8-1A0A024RDC4Q05CA1
PRDM8NM_020226.4 linkc.1412G>A p.Ser471Asn missense_variant Exon 10 of 10 NP_064611.3 Q9NQV8-1A0A024RDC4Q05CA1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRDM8ENST00000415738.3 linkc.1412G>A p.Ser471Asn missense_variant Exon 4 of 4 1 NM_001099403.2 ENSP00000406998.2 Q9NQV8-1
PRDM8ENST00000339711.8 linkc.1412G>A p.Ser471Asn missense_variant Exon 10 of 10 1 ENSP00000339764.4 Q9NQV8-1
PRDM8ENST00000504452.5 linkc.1412G>A p.Ser471Asn missense_variant Exon 8 of 8 5 ENSP00000423985.1 Q9NQV8-1
PRDM8ENST00000515013.5 linkc.*129G>A downstream_gene_variant 1 ENSP00000425149.1 E9PEH0

Frequencies

GnomAD3 genomes
AF:
0.000583
AC:
88
AN:
150984
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00165
Gnomad ASJ
AF:
0.000868
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000576
Gnomad OTH
AF:
0.000962
GnomAD2 exomes
AF:
0.00633
AC:
1
AN:
158
AF XY:
0.0111
show subpopulations
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00658
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000419
AC:
470
AN:
1122944
Hom.:
2
Cov.:
36
AF XY:
0.000506
AC XY:
273
AN XY:
539100
show subpopulations
African (AFR)
AF:
0.0000444
AC:
1
AN:
22540
American (AMR)
AF:
0.000625
AC:
5
AN:
8000
Ashkenazi Jewish (ASJ)
AF:
0.000421
AC:
6
AN:
14236
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25368
South Asian (SAS)
AF:
0.00429
AC:
129
AN:
30090
European-Finnish (FIN)
AF:
0.0000834
AC:
2
AN:
23982
Middle Eastern (MID)
AF:
0.00200
AC:
6
AN:
2996
European-Non Finnish (NFE)
AF:
0.000309
AC:
294
AN:
950584
Other (OTH)
AF:
0.000598
AC:
27
AN:
45148
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
27
54
81
108
135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000576
AC:
87
AN:
151092
Hom.:
0
Cov.:
32
AF XY:
0.000569
AC XY:
42
AN XY:
73838
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41412
American (AMR)
AF:
0.00165
AC:
25
AN:
15172
Ashkenazi Jewish (ASJ)
AF:
0.000868
AC:
3
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5114
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10152
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000576
AC:
39
AN:
67658
Other (OTH)
AF:
0.000952
AC:
2
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000693
Hom.:
0
Bravo
AF:
0.000518

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Early-onset Lafora body disease Uncertain:1
Jan 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 471 of the PRDM8 protein (p.Ser471Asn). This variant is present in population databases (rs575791037, gnomAD 0.4%). This variant has not been reported in the literature in individuals affected with PRDM8-related conditions. ClinVar contains an entry for this variant (Variation ID: 542337). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
14
DANN
Benign
0.93
DEOGEN2
Benign
0.011
T;T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.056
N
LIST_S2
Benign
0.40
.;T;.
M_CAP
Benign
0.076
D
MetaRNN
Benign
0.0038
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N;N
PhyloP100
0.30
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.26
N;N;N
REVEL
Benign
0.0070
Sift
Benign
0.46
T;T;T
Sift4G
Benign
0.27
T;T;T
Polyphen
0.0080
B;B;B
Vest4
0.042
MVP
0.41
ClinPred
0.026
T
GERP RS
1.6
Varity_R
0.051
gMVP
0.099
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs575791037; hg19: chr4-81124028; API